Navigation Links
Valeant Pharmaceuticals to Announce 2011 First Quarter Results on May 9, 2011
Date:4/29/2011

MISSISSAUGA, Ontario, April 29, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Monday, May 9, 2011 at 10:00 a.m. ET (7:00 a.m. PT) to discuss results for the 2011 first quarter.

The dial-in number to participate on this call is (877) 295-5743, confirmation code 63195016.  International callers should dial (973) 200-3961, confirmation code 63195016. A replay will be available approximately two hours following the conclusion of the conference call to Monday, May 16, 2011, and can be accessed by dialing (800) 642-1687 or (706) 645-9291, confirmation code 63195016.

The webcast and slide presentation will be hosted in the investor relations section of its corporate Web site at www.valeant.com. Participants should allow approximately five to 10 minutes prior to the call's start time to visit the site and to download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at www.valeant.com.

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant can be found at www.valeant.com.

(Logo:  http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com


'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
2. Valeant Pharmaceuticals Announces Redemption of 4.0% Convertible Subordinated Notes Due 2013
3. Regulatory Update - GSK and Valeant Respond to FDA on ezogabine
4. Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors
5. Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
6. Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
7. Promius Pharma and Valeant Form Collaboration to Market Cloderm® Cream in the United States
8. Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
9. GSK and Valeant Receive European Authorisation for Trobalt (retigabine)
10. Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
11. Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), ... fiscal year ended December 31, 2016. ... This news release should ... and management discussion and analysis for the years ended December ... and are available at www.sedar.com and on the ...
(Date:2/22/2017)... Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) ... 2016 investor conference call and webcast at 8:30 a.m., Eastern ... will cover an update on Merrimack,s recent progress as well ... financial results. A press release detailing the information to be ... Wednesday, March 1. Investors and the general public are invited ...
(Date:2/22/2017)... 2017 Summary Provides understanding and ... and agreements entered into by the worlds leading healthcare ... Description The Global Non-Small Cell Lung Cancer Partnering ... access to partnering deals and agreements entered into by ... in partnering deals - Top deals by value ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... 22, 2017 , ... ANGLESTRONG , the new recovery management app with ... App Store and Google Play . Florida-based Sober Network, Inc., the ... industry, partnered with Angle to build ANGLESTRONG. The new recovery management app is a ...
(Date:2/22/2017)... ... February 22, 2017 , ... A product of digesting a ... derive a heart-protective benefit from eating soy foods, while others do not, a University ... are able to produce equol—a substance made by some types of “good” gut bacteria ...
(Date:2/22/2017)... ... 2017 , ... Super-Sod will attend the Athens Home Show with a brand ... shift from Super-Sod’s simple Athens Home Show booth of 2016, this year’s exhibit space ... manager Chris Roquemore constructed furniture from recycled pallet wood at the Super-Sod farm in ...
(Date:2/22/2017)... ... February 22, 2017 , ... BrightStar Care Charleston , a home ... University of South Carolina (MUSC) Center on Aging’s Senior Expo on Thursday, March ... Aging is a tremendous resource in our community. We are thrilled to participate in ...
(Date:2/22/2017)... ... February 22, 2017 , ... Apptricity® Corporation, a leading global ... management, today announced that Keppel Corporation has selected Apptricity Travel and Expense Management ... “We are excited to announce the partnership between Keppel and Apptricity for our ...
Breaking Medicine News(10 mins):